Pharmacosmos is looking for a Specialist, PV Partner Management to join our Drug Safety department, and to work closely with the Director, QPPV Office to manage PV Partners including PV partner agreements, to further develop our post-marketing pharmacovigilance system and ensure regulatory compliance.
The Drug Safety department is part of R&D at Pharmacosmos. We are a small group of four experienced and dedicated colleagues, managing global drug safety for our human and veterinary products. We are looking forward to welcoming you as an important part of the team in a progressive and innovative pharmaceutical company. You will work closely together with internal stakeholders such as R&D, Quality & Regulatory Affairs, Medical Affairs, Sales & Marketing, as well as with our external collaboration partners across the world.
You will be responsible for:
The position reports to Head of Drug Safety and QPPV.
As a professional, we expect you to:
As a person we expect you to:
Rekrutteringskompagniet A/S is responsible for the recruitment process on behalf of Pharmacosmos A/S. Further information about the position can be obtained by contacting Partner Berit Tops, on +45 2174 2322 (after February 24, 2020) or Researcher Sasja Winther, on + 45 8119 2939. Your application and CV (in English) should be submitted to us as soon as possible and no later than March 9, 2020.
Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.
A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.
Pharmacosmos has subsidiaries in US, UK, Ireland, Germany, Sweden and Norway and its products are marketed in more than 80 countries around the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.
Vi takker for din henvendelse og vender tilbage til dig hurtigst muligt
You are now leaving Pharmacosmos.com. The website you are about to visit is is a Pharmacosmos subsidary. Do you want to proceed?